Guardian Pharmacy Services (NYSE:GRDN) Price Target Raised to $25.00 at Truist Financial
Guardian Pharmacy Services (NYSE:GRDN – Free Report) had its price objective hoisted by Truist Financial from $24.00 to $25.00 in a research report released on Friday morning,Benzinga reports. Truist Financial currently has a buy rating on the stock. Guardian Pharmacy Services Price Performance GRDN opened at $22.81 on Friday. The stock’s 50 day moving average […]
More Stories
Saks Fifth Avenue to Close Store in San Francisco’s Union Square
By Jill McLaughlin Luxury department chain Saks Fifth Avenue confirmed April 25 that it will close its Union Square location...
Open Hip Joints to Avoid Knee Pain in Sitting Cross-Legged Positions
By Amber Yang Many people use meditation to relieve stress. However, if you choose to meditate while sitting in the...
Trump Says He Hopes Ukraine Will Immediately Sign Minerals Deal
By Tom Ozimek U.S. President Donald Trump said on Friday that Ukraine hasn’t signed a long-delayed rare earths agreement that...
Politicians and Pilgrims Alike Gather for Pope Francis’s Funeral
By T.J. Muscaro The sun rose high over a packed St. Peter’s Square on the morning of April 26 as...
Elevance Health (NYSE:ELV) Earns “Overweight” Rating from Cantor Fitzgerald
Cantor Fitzgerald reiterated their overweight rating on shares of Elevance Health (NYSE:ELV – Free Report) in a research note released...
Elevance Health’s (ELV) Outperform Rating Reiterated at Royal Bank of Canada
Royal Bank of Canada reiterated their outperform rating on shares of Elevance Health (NYSE:ELV – Free Report) in a research...